BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional ...
BLOOMFIELD HILLS, Mich., August 23, 2024--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional ...
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional ...
A reduction in viral titers (viral shedding) in infected birds receiving ZIVO’s products compared with untreated infected controls. A delay in transmission of LPAI when healthy birds were exposed to ...
The average one-year price target for Zivo Bioscience (NASDAQ:ZIVO) has been revised to 36.72 / share. This is an increase of 500.00% from the prior estimate of 6.12 dated October 4, 2023. The price ...
ZIVO Bioscience, Inc. (OTCQB:ZIVO) is a research and development (R&D) company operating in the biotech as well as the agritech sectors, with an intellectual property (IP) portfolio comprising ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback